SEC Form D filing

Star Therapeutics LLC, 2025-10-06

An SEC Form D private-offering notice from South San Francisco, CA, a $124,999,974 filer-stated offering target in Biotech. Filed 2025-10-06. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Star Therapeutics LLC site↗ Verified via SEC Form D

Clinical stage biotechnology company developing antibody therapies for bleeding disorders, including a first in class candidate for von Willebrand disease.

Filed 2025-10-06Filed to raise $124,999,974First money in 2025-09-22Raised so far $124,999,974HQ (as filed) South San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified star-therapeutics.com↗Named in the filing 12 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source